Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Redhill Biopharma Ltd. - American Depositary Shares
(NQ:
RDHL
)
1.028
-0.002 (-0.21%)
Streaming Delayed Price
Updated: 10:12 AM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Redhill Biopharma Ltd. - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 05, 2025
Via
Benzinga
Why Intuitive Surgical Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
↗
October 22, 2025
Via
Benzinga
RedHill Biopharma Logs Best Session In Over A Year After $10M Legal Victory — Retail Sees Bullish Triggers Ahead
↗
September 29, 2025
Via
Stocktwits
Wondering what's happening in today's pre-market session?
↗
September 29, 2025
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
Why Is RedHill Biopharma (RDHL) Stock Up 75% Today?
↗
August 01, 2024
One of today's biggest market movers in the biotech space is RedHill Biuopharma, with RDHL stock up more than 75% on big news.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
September 29, 2025
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 13, 2025
Via
Benzinga
Get insights into the top gainers and losers of Monday's after-hours session.
↗
July 21, 2025
The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
Which stocks are experiencing notable movement on Monday?
↗
July 21, 2025
Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
July 21, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
July 18, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
July 18, 2025
Via
Benzinga
Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
↗
July 18, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 17, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
April 21, 2025
Via
Benzinga
On Thursday, there are stocks with unusual volume. Let's take a look.
↗
April 17, 2025
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Via
Chartmill
Which stocks are moving after the closing bell on Wednesday?
↗
April 16, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
February 13, 2025
Via
Benzinga
New Prostate Cancer Hope? Bayer-Funded Phase 2 Study To Test Combination Of RedHill's Opaganib And Bayer’s Darolutamide, To Overcome Androgen Resistance
February 05, 2025
New Prostate Cancer Hope? Bayer-Funded Phase 2 Study To Test Combination Of RedHill's Opaganib And Bayer’s Darolutamide, To Overcome Androgen Resistance
Via
News Direct
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
January 21, 2025
Via
Benzinga
Supreme Court Of New York Awards RedHill Biopharma Approx. $8 Million Plus Costs In Breach Of Contract Lawsuit
December 09, 2024
Supreme Court Of New York Awards RedHill Biopharma Approx. $8 Million Plus Costs In Breach Of Contract Lawsuit
Via
News Direct
Topics
Lawsuit
RedHill Biopharma Secures U.S. Government Funding Through BARDA To Advance Opaganib For Ebola Treatment
October 15, 2024
RedHill Biopharma Secures U.S. Government Funding Through BARDA To Advance Opaganib For Ebola Treatment
Via
News Direct
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 03, 2024
Via
Benzinga
RedHill's Opaganib Shows Diabetes And Obesity Potential With Positive In Vivo Results
August 23, 2024
RedHill's Opaganib Shows Diabetes And Obesity Potential With Positive In Vivo Results
Via
News Direct
Israel-Based RedHill's Investigational COVID-19 Treatment Shows Encouraging Action In Obesity And Diabetes
↗
August 19, 2024
RedHill Biopharma released study results showing opaganib's potential in treating Type 2 diabetes and obesity. The drug's ability to target sphingolipid metabolism could help prevent weight gain and...
Via
Benzinga
Crude Oil Moves Lower; Moderna Shares Plunge
↗
August 01, 2024
Via
Benzinga
Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July
↗
August 01, 2024
Via
Benzinga
Topics
Stocks
Nasdaq Surges 1%; Meta Posts Upbeat Earnings
↗
August 01, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
